↓ Skip to main content

New Routes in GPCR/β-Arrestin-Driven Signaling in Cancer Progression and Metastasis

Overview of attention for article published in Frontiers in Pharmacology, February 2019
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
4 X users

Citations

dimensions_citation
40 Dimensions

Readers on

mendeley
86 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
New Routes in GPCR/β-Arrestin-Driven Signaling in Cancer Progression and Metastasis
Published in
Frontiers in Pharmacology, February 2019
DOI 10.3389/fphar.2019.00114
Pubmed ID
Authors

Anna Bagnato, Laura Rosanò

X Demographics

X Demographics

The data shown below were collected from the profiles of 4 X users who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 86 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 86 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 15 17%
Student > Bachelor 12 14%
Student > Ph. D. Student 12 14%
Student > Master 10 12%
Professor 4 5%
Other 8 9%
Unknown 25 29%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 23 27%
Agricultural and Biological Sciences 9 10%
Pharmacology, Toxicology and Pharmaceutical Science 8 9%
Immunology and Microbiology 4 5%
Medicine and Dentistry 3 3%
Other 9 10%
Unknown 30 35%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 08 March 2019.
All research outputs
#14,155,832
of 23,132,033 outputs
Outputs from Frontiers in Pharmacology
#4,440
of 16,510 outputs
Outputs of similar age
#190,169
of 352,636 outputs
Outputs of similar age from Frontiers in Pharmacology
#195
of 367 outputs
Altmetric has tracked 23,132,033 research outputs across all sources so far. This one is in the 37th percentile – i.e., 37% of other outputs scored the same or lower than it.
So far Altmetric has tracked 16,510 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.0. This one has gotten more attention than average, scoring higher than 71% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 352,636 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 44th percentile – i.e., 44% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 367 others from the same source and published within six weeks on either side of this one. This one is in the 44th percentile – i.e., 44% of its contemporaries scored the same or lower than it.